Immutep Limited - Asset Resilience Ratio

Latest as of December 2025: 17.92%

Immutep Limited (YP1A) has an Asset Resilience Ratio of 17.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See YP1A current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€26.38 Million

≈ $30.84 Million USD Cash + Short-term Investments

Total Assets

€147.20 Million

≈ $172.09 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Immutep Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Immutep Limited balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Immutep Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Immutep Limited debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€26.38 Million	17.92%
Total Liquid Assets	€26.38 Million	17.92%

Asset Resilience Insights

Good Liquidity Position: Immutep Limited maintains a healthy 17.92% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Immutep Limited Industry Peers by Asset Resilience Ratio

Compare Immutep Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Immutep Limited (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Immutep Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	9.96%	€20.09 Million ≈ $23.48 Million	€201.58 Million ≈ $235.67 Million	--
2023-06-30	0.00%	€0.00 ≈ $0.00	€147.45 Million ≈ $172.38 Million	--

pp = percentage points

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$39.28 Million

€33.60 Million EUR

Market Cap Rank

#22890 Global

#2002 in Germany

Share Price

€0.23

Change (1 day)

-14.29%

52-Week Range

€0.23 - €2.64

All Time High

€4.52